VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
Illustration for: Jaovi Inc Files Small S-1 From Costa Rica
Value Add VC/Pulse/IPO$120,000 total offering

Jaovi Inc Files Small S-1 From Costa Rica

Wyoming-incorporated Jaovi Inc, based in Costa Rica, filed an S-1 registering 4 million shares at $0.03 each for a total offering of just $120,000 -- illustrating the far end of the small-cap IPO pipeline.

By the Numbers

July 8, 2026
Filing date
4,000,000
Shares registered
$0.03/share
Max offering price
$120,000
Total max offering
TC
By the IPO Desk
Edited by Trace Cohen · Early-stage VC & angel · Founder, New York Venture Partners
July 8, 2026
2 min read
ShareXLinkedInEmail

THE RUNDOWN

1

Jaovi Inc filed a Form S-1 with the SEC dated July 8, registering 4,000,000 shares of common stock at a maximum offering price of $0.03 per share, for a total maximum aggregate offering of $120,000

2

The company is incorporated in Wyoming but headquartered in Puerto Cortes de Osa, Puntarenas, Costa Rica, reflecting the common pattern of small, early-stage companies incorporating in a US state for public-market access while operating internationally

3

A $120,000 total offering size sits at the extreme small end of the S-1 pipeline, orders of magnitude below even the smaller distressed filings from companies like Mobix Labs or Zapata Quantum, let alone the AI-infrastructure mega-deals dominating headlines

4

Jaovi's filing is a useful illustration of just how wide the range of company sizes and ambitions moving through the SEC's registration process actually is in any given week, from six-figure micro-offerings to multi-billion-dollar private mega-rounds happening entirely outside the public markets

TC

The VC Read · Trace's Take

Trace Cohen

A $120,000 total offering next to Anthropic's $50B round in the same week's SEC and funding news is the cleanest illustration you'll find of how absurdly wide the range of 'capital markets activity' actually is right now. Treat filings at this scale as exactly what they are -- a legal process, not a signal of quality -- and do real diligence before anyone calls this the next anything.

Analysis

Jaovi Inc filed a Form S-1 registration statement with the SEC dated July 8, registering 4,000,000 shares of common stock at a maximum offering price of $0.03 per share -- a total maximum aggregate offering of just $120,000. The company is incorporated in Wyoming but headquartered in Puerto Cortes de Osa, Puntarenas, Costa Rica, a common structure for small, early-stage companies that incorporate in a US state specifically for access to US public markets while operating internationally.

At $120,000, Jaovi's total offering size sits at the extreme micro end of the S-1 pipeline -- orders of magnitude smaller than even the distressed small-cap filings from companies like Mobix Labs or Zapata Quantum, and negligible relative to the billions of dollars moving through private AI-infrastructure mega-rounds in the same news cycle. Filings at this scale are typically shell or micro-cap companies in the earliest stages of seeking public-market access, often with minimal operating history or revenue disclosed at the time of filing.

The existence of a filing this small alongside this week's headline-grabbing mega-deals is itself the useful data point: the SEC's registration process serves companies across an almost incomprehensibly wide range of scale, from six-figure micro-offerings like Jaovi's to the multi-billion-dollar private rounds that increasingly bypass public markets altogether, as Anthropic's $50 billion Series H and Mercor's reported $20 billion valuation talks illustrate.

For investors scanning the small-cap and micro-cap S-1 pipeline, a filing at Jaovi's scale requires an entirely different due-diligence framework than a growth-stage or late-stage offering -- the company's limited size and disclosed operating history typically mean much higher execution and fraud risk relative to any potential return. For founders considering a public-market path, Jaovi's filing is a reminder that S-1 registration itself is a relatively accessible legal process available to companies of nearly any size, not a signal of institutional validation on its own.

The bear case is straightforward given the offering's scale: micro-cap S-1 filings of this size carry disproportionately high risk of thin trading, limited investor protections in practice, and minimal analyst or institutional coverage once listed. What to watch next: whether Jaovi's registration statement becomes effective and the company completes its offering, and what its actual business operations and revenue disclosures show once fuller filings become available.

Related Deep Dives

  • Unitree IPO 2026: $6.2B STAR Market Valuation Ranked Agai... →
  • $251B Raised, 86 Deals — IPO Market (2026) →
  • Anthropic Stock: Can You Buy It? The $965B Company Blocke... →
ShareXLinkedInEmail

Key Sources

2 sources
SourceSEC EDGAR
AnalysisValue Add Pulse

Reported by SEC EDGAR · Analysis by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPO· Aug 21, 2026

Anthropic's IPO Filing Will Flag AI Backlash as Risk

Illustration for: Anthropic's IPO Filing Will Flag AI Backlash as Risk
IPO

Anthropic's IPO Filing Will Flag AI Backlash as Risk

Anthropic's forthcoming IPO filing will include AI backlash -- public and regulatory skepticism toward the industry -- as a formal risk factor, sources tell CNBC, an unusually candid disclosure for a company chasing SpaceX's record size.

IPO· Aug 21, 2026

Three SPACs File This Week Hunting for Targets

Illustration for: Three SPACs File This Week Hunting for Targets
IPO

Three SPACs File This Week Hunting for Targets

Dune Acquisition Corp III, Albatross Acquisition Corp and Three Lions Acquisition Corp all filed amended S-1 registrations this week, adding to a modest but real pipeline of blank-check vehicles still working through the SEC process.

IPO· Aug 21, 2026

Three Biotechs File S-1s in the Same Week

Illustration for: Three Biotechs File S-1s in the Same Week
IPO

Three Biotechs File S-1s in the Same Week

Tempest Therapeutics, Aptevo Therapeutics and Alzamend Neuro all filed S-1 registration statements this week, a reminder that the biotech IPO pipeline keeps moving even in a news cycle dominated by trillion-dollar AI listings.

Deep Dives

Unitree IPO 2026: $6.2B STAR Market Valuation Ranked Agai...$251B Raised, 86 Deals — IPO Market (2026)Anthropic Stock: Can You Buy It? The $965B Company Blocke...
@Trace_Cohen·t@nyvp.com